Condition
Steroids
Total Trials
6
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 3 (1)
P 4 (1)
Trial Status
Completed3
Recruiting2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07078786Phase 4Recruiting
Effect of Pre-delivery Dexamethasone in Comparison With Betamethasone on Fetal Heart Trace
NCT04266977Not ApplicableRecruiting
Restrictive Use of Dexamethasone in Glioblastoma
NCT02944045Phase 3Unknown
Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients
NCT04445506Completed
Short Term Corticosteroids in SARS-CoV2 Patients
NCT01564355Not ApplicableCompleted
Postoperative Systemic Corticosteroids When Utilizing a Steroid-Eluting Spacer Following Endoscopic Sinus Surgery
NCT00713440Not ApplicableCompleted
Incretin Physiology Associated With Steroid Hormone Treatment
Showing all 6 trials